Larimar Therapeutics Cash Flow Statement (2013-2020) | LRMR

Cash Flow Statement Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020
Operating Activities
Net Income -4.52M-6.43M-14.57M-10.85M-13.41M-17.76M-19.77M-23.23M-17.81M-14.98M-14.73M-10.34M-13.11M-13.34M-12.61M-13.11M-15.89M-15.70M-15.02M-14.52M-13.13M-12.11M-12.88M-7.31M-3.61M
Depreciation and Depletion 0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.04M0.05M0.05M0.05M0.06M0.04M0.05M0.05M0.05M0.05M0.05M0.11M0.05M0.05M-0.01M0.02M0.02M0.02M0.03M0.05M0.05M
Share-based Compensation 0.10M0.14M0.18M0.27M0.47M2.66M1.06M1.94M2.84M2.75M2.76M2.85M2.32M2.01M2.00M2.10M2.10M2.10M2.47M2.67M2.20M2.29M2.08M0.03M0.03M0.03M0.03M0.75M0.37M1.01M
Gains from Sales and Divestitures 0.02M
Gains from Investment Securities 0.34M0.99M2.00M1.53M2.25M2.01M2.24M1.21M1.68M1.46M2.26M5.02M1.99M0.07M0.45M
Cash from Restructuring -0.91M-1.73M
Non-cash Items 1.04M3.25M3.14M2.70M1.70M0.54M5.30M
Cash from Operations -3.44M-4.13M-4.02M-6.23M-6.28M-11.71M-11.09M-14.39M-16.14M-17.94M-17.76M-14.52M-11.03M-8.67M-11.68M-10.18M-12.09M-9.84M-13.27M-13.31M-13.08M-11.83M-12.47M3.51M-5.82M-7.91M-8.92M-12.20M-11.22M-9.86M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.13M0.25M0.38M0.49M0.41M0.31M0.22M-1.97M-0.06M-0.08M-0.07M-0.03M0.01M0.09M0.25M0.33M0.28M0.26M0.16M0.08M0.05M-0.00M
Amortization of Deferred Charges 0.02M0.01M0.02M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.00M0.00M
Depreciation & Amortization (CF) 0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.04M0.05M0.05M0.05M0.06M0.04M0.05M0.05M0.05M0.05M0.05M0.11M0.05M0.05M-0.01M0.02M0.02M0.02M0.03M0.05M0.05M
Change in Working Capital
Change in Account Payables 0.64M0.12M-0.51M0.61M-0.51M1.23M1.12M0.89M-0.17M3.07M-4.05M-0.66M1.15M-1.07M-0.66M2.54M-1.77M0.34M0.78M-0.93M-0.25M0.83M-0.45M1.10M1.55M0.43M-2.52M-0.76M-0.91M0.91M
Change in Accured Expenses -0.68M-0.63M0.35M0.44M8.29M-6.75M0.99M0.45M2.16M-0.41M0.69M-1.73M-0.37M-0.84M0.13M-1.13M0.39M1.19M-0.53M0.94M0.69M-0.48M-1.12M1.13M1.60M-0.67M0.23M0.84M-0.35M2.52M
Change in Taxes 0.03M0.09M
Other Working Capital Changes -0.07M-0.01M0.04M1.10M-0.15M0.12M0.39M-0.59M0.75M-0.18M-0.44M0.06M0.12M-0.16M0.02M0.23M0.40M-0.08M-0.51M-0.13M1.10M-0.66M-0.47M1.79M0.33M1.63M0.01M1.75M0.08M-0.19M
Investing Activities
Capital Expenditures 0.00M0.01M0.01M0.01M0.03M0.02M0.03M0.12M0.07M0.37M0.40M0.26M0.01M0.01M0.01M0.03M0.00M0.03M0.07M0.01M0.01M0.02M0.05M0.06M0.01M0.40M
Change in Acquisitions & Divestments 29.25M50.47M59.70M56.57M49.13M39.52M52.71M47.23M41.49M38.50M32.17M38.05M30.84M31.35M22.75M25.45M34.27M41.79M25.85M7.55M20.53M
Cash from Investing Activities -0.00M-0.01M-0.01M-0.06M-0.03M-57.22M-69.73M-9.34M-28.51M15.46M14.27M3.82M16.44M16.91M8.69M13.99M0.28M12.69M17.96M8.34M-47.44M14.27M0.81M-0.84M-0.05M-0.78M41.42M-0.01M-23.55M
Financing Activities
Other financing activities 0.03M0.83M0.59M0.89M0.47M0.02M
Cash from Financing Activities -0.17M34.81M6.99M102.04M-0.89M0.00M129.65M0.36M-0.16M-0.68M-0.66M-0.73M-0.58M-0.76M-0.73M-0.71M-0.72M18.73M0.26M-0.02M64.91M1.76M0.10M5.89M9.95M3.46M9.58M83.90M-0.14M0.24M
Additional items
Change in Cash -3.61M30.67M2.97M95.75M-7.20M-68.93M48.83M-23.36M-44.81M-3.17M-4.14M-11.42M4.83M7.49M-3.72M3.09M-12.53M21.58M4.95M-4.99M4.40M4.19M-11.57M8.56M4.13M-4.51M-0.12M113.12M-11.37M-33.16M
Beginning Cash Balance 8.45M4.84M35.52M38.48M134.23M127.03M58.10M106.93M83.57M38.76M35.59M31.45M20.03M24.86M32.35M28.63M31.73M19.19M40.78M45.73M40.74M45.14M47.99M28.68M39.21M5.51M39.10M-0.45M112.67M33.16M
Free Cash Flow -3.44M-4.14M-4.03M-6.24M-6.31M-11.73M-11.11M-14.51M-16.21M-18.32M-18.16M-14.78M-11.03M-8.67M-11.69M-10.19M-12.10M-9.86M-13.27M-13.34M-13.15M-11.85M-12.48M3.48M-5.82M-7.96M-8.98M-12.20M-11.23M-10.25M
Net Cash Flow -3.61M30.67M2.97M95.75M-7.20M-68.93M48.83M-23.36M-44.81M-3.17M-4.14M-11.42M4.83M7.49M-3.72M3.09M-12.53M21.58M4.95M-4.99M4.40M4.19M-11.57M8.56M4.13M-4.51M-0.12M113.12M-11.37M-33.16M